ATE301186T1 - Verfahren zur sterilisation biologischer zusammensetzungen und das dabei erhaltene produkt - Google Patents

Verfahren zur sterilisation biologischer zusammensetzungen und das dabei erhaltene produkt

Info

Publication number
ATE301186T1
ATE301186T1 AT94919293T AT94919293T ATE301186T1 AT E301186 T1 ATE301186 T1 AT E301186T1 AT 94919293 T AT94919293 T AT 94919293T AT 94919293 T AT94919293 T AT 94919293T AT E301186 T1 ATE301186 T1 AT E301186T1
Authority
AT
Austria
Prior art keywords
composition
type
compound
irradiation
reactions
Prior art date
Application number
AT94919293T
Other languages
English (en)
Inventor
Bernard Horowitz
Bolanle Williams
Henrietta Margolis-Nunno
Sing N Chin
Original Assignee
New York Blood Ct Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Blood Ct Inc filed Critical New York Blood Ct Inc
Application granted granted Critical
Publication of ATE301186T1 publication Critical patent/ATE301186T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0023—Aggression treatment or altering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0066—Psoralene-activated UV-A photochemotherapy (PUVA-therapy), e.g. for treatment of psoriasis or eczema, extracorporeal photopheresis with psoralens or fucocoumarins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20261—Methods of inactivation or attenuation
    • C12N2760/20263—Methods of inactivation or attenuation by chemical treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32661—Methods of inactivation or attenuation
    • C12N2770/32663—Methods of inactivation or attenuation by chemical treatment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10161—Methods of inactivation or attenuation
    • C12N2795/10163—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT94919293T 1993-05-28 1994-05-27 Verfahren zur sterilisation biologischer zusammensetzungen und das dabei erhaltene produkt ATE301186T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6923593A 1993-05-28 1993-05-28
PCT/US1994/006077 WO1994028120A1 (en) 1991-05-10 1994-05-27 Process for the sterilization of biological compositions and the product produced thereby

Publications (1)

Publication Number Publication Date
ATE301186T1 true ATE301186T1 (de) 2005-08-15

Family

ID=22087612

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94919293T ATE301186T1 (de) 1993-05-28 1994-05-27 Verfahren zur sterilisation biologischer zusammensetzungen und das dabei erhaltene produkt

Country Status (12)

Country Link
EP (1) EP0702719B1 (de)
JP (1) JP3426237B2 (de)
KR (1) KR100258377B1 (de)
AT (1) ATE301186T1 (de)
AU (1) AU696246B2 (de)
CA (1) CA2163636C (de)
DE (1) DE69434445T2 (de)
ES (1) ES2247587T3 (de)
FI (1) FI117288B (de)
NO (1) NO954815L (de)
WO (1) WO1994028120A1 (de)
ZA (1) ZA943754B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077659A (en) * 1990-05-15 2000-06-20 New York Blood Center, Inc. Vitamin E and derivatives thereof prevent potassium ion leakage and other types of damage in red cells that are virus sterilized by phthalocyanines and light
EP0840624B1 (de) * 1995-07-14 2007-07-25 CAF - DCF cvba - scrl Vorrichtung zur inaktivierung von viralen kontaminationen in blutprodukten
US7049110B2 (en) 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US6329136B1 (en) 1998-10-30 2001-12-11 The Regents Of The University Of California Method for laser inactivation of infectious agents
US6635676B2 (en) * 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
US7655252B2 (en) 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
WO2001087357A2 (en) * 2000-05-17 2001-11-22 The American National Red Cross Gamma irradiation of protein-based pharmaceutical products
JP2010209109A (ja) * 2001-06-25 2010-09-24 Regents Of The Univ Of Michigan 抗微生物ナノエマルジョンの組成物および方法
WO2003063902A2 (en) * 2002-02-01 2003-08-07 Gambro, Inc. Inactivation of west nile virus and plasmodium falciparum using alloxazine-derivating photosensitizers
AU2004216476B2 (en) 2003-02-27 2009-01-08 Takeda Pharmaceutical Company Limited Method for the validatable inactivation of pathogens in a biological fluid by irradiation
WO2009131606A2 (en) * 2008-02-01 2009-10-29 Belanger Julie M Viral inactivation using crosslinkers and detergents
US8613934B2 (en) 2004-03-22 2013-12-24 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Cellular and viral inactivation
WO2005099757A1 (de) 2004-04-16 2005-10-27 Helbo Photodynamic Systems Gmbh & Co.Kg Aufbereitung für photodynamische bekämpfung von mikroorganismen und verwendung der aufbereitung
KR101226665B1 (ko) 2004-04-16 2013-01-25 브레덴트 메디칼 게엠베하 운트 코. 카게 미생물의 광역학적 제어를 위한 제제 및 상기 제제의 사용
DE102006008613A1 (de) * 2006-02-24 2007-08-30 Dade Behring Marburg Gmbh Stabilisierte Zubereitungen von Serin-Endopeptidasen, deren Herstellung und Verwendung
US8580192B2 (en) 2006-10-31 2013-11-12 Ethicon, Inc. Sterilization of polymeric materials
WO2008137747A1 (en) 2007-05-02 2008-11-13 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
EP2008669A1 (de) * 2007-06-22 2008-12-31 Maco Pharma S.A. Bestrahlungsvorrichtung zur Deaktivierung von Krankheitserregern und/oder Leukozyten in einer biologischen Flüssigkeit und entsprechendes Verfahren
CA2743904A1 (en) 2008-11-17 2010-05-20 The Regents Of The University Of Michigan Cancer vaccine compositions and methods of using the same
CA2797059A1 (en) * 2010-05-03 2011-11-10 Glaxosmithkline Biologicals S.A. Novel method
EA201992617A1 (ru) * 2011-10-26 2020-03-10 Амген Инк. Способы уменьшения или устранения модификации и разложения белка, обусловленных воздействием уф-излучения
KR101936559B1 (ko) * 2016-07-13 2019-01-09 국립암센터 분해가능 연결자를 포함하는 광증감제-펩타이드 결합체 및 그를 포함하는 광역학 진단 또는 치료용 조성물
ES2991988T3 (es) 2017-10-30 2024-12-05 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivación de virus con envoltura lipídica
AU2018395525B2 (en) 2017-12-29 2023-09-14 Cerus Corporation Systems and methods for treating biological fluids
US12011510B2 (en) 2019-06-22 2024-06-18 Cerus Corporation Biological fluid treatment systems
JP7571063B2 (ja) 2019-06-22 2024-10-22 シーラス コーポレイション 生物学的流体の処理を実施するシステム及び方法
CN114269394A (zh) 2019-06-28 2022-04-01 塞鲁斯公司 用于实现生物流体处理装置的系统和方法
EP4268849A4 (de) 2020-12-24 2024-12-25 National University Corporation Kobe University Verfahren zur virusinaktivierung mittels ultravioletter bestrahlung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049798A (en) * 1974-12-11 1977-09-20 William K. Bottomley Method for the treatment of Herpes Simplex
US4693981A (en) * 1983-12-20 1987-09-15 Advanced Genetics Research Institute Preparation of inactivated viral vaccines
JPS61275228A (ja) * 1985-03-14 1986-12-05 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド 治療用タンパク組成物中のビ−ルスの光動的不活性化
JPH01175942A (ja) * 1987-12-28 1989-07-12 Sanyo Kokusaku Pulp Co Ltd 抗ウイルス性医薬用組成物
GB8817240D0 (en) * 1988-07-20 1988-08-24 Univ Salford Business Services Sterilising methods
US5120649A (en) * 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
US5232844A (en) * 1990-05-15 1993-08-03 New York Blood Center Photodynamic inactivation of viruses in cell-containing compositions
US5211944A (en) * 1990-10-12 1993-05-18 Shaman Pharmaceuticals, Inc. Proanthocyanidin polymers having antiviral activity and methods of obtaining same

Also Published As

Publication number Publication date
CA2163636A1 (en) 1994-12-08
AU7048594A (en) 1994-12-20
NO954815D0 (no) 1995-11-27
ZA943754B (en) 1995-02-09
FI117288B (fi) 2006-08-31
WO1994028120A1 (en) 1994-12-08
KR960702864A (ko) 1996-05-23
EP0702719B1 (de) 2005-08-03
JPH11503601A (ja) 1999-03-30
EP0702719A1 (de) 1996-03-27
DE69434445D1 (de) 2005-09-08
ES2247587T3 (es) 2006-03-01
CA2163636C (en) 2002-01-08
FI955690L (fi) 1996-01-22
EP0702719A4 (de) 1996-08-14
KR100258377B1 (ko) 2000-06-01
NO954815L (no) 1996-01-26
JP3426237B2 (ja) 2003-07-14
AU696246B2 (en) 1998-09-03
FI955690A0 (fi) 1995-11-24
DE69434445T2 (de) 2006-05-18

Similar Documents

Publication Publication Date Title
ATE301186T1 (de) Verfahren zur sterilisation biologischer zusammensetzungen und das dabei erhaltene produkt
DE60021403T2 (de) Isoalloxazinderivate zur neutralisierung von biologischen schmutzstoffen
KR960703625A (ko) 제품의 살균방법(method for sterilizing products)
ATA323784A (de) Verfahren zur inaktivierung von vermehrungsfaehigen filtrierbaren krankheitserregern in blutprodukten
EA200100502A1 (ru) СПОСОБЫ И КОМПОЗИЦИЯ ДЛЯ ВОССТАНОВЛЕНИЯ КОНФОРМАЦИОННОЙ СТАБИЛЬНОСТИ БЕЛКА СЕМЕЙСТВА p53
EA200000298A1 (ru) Агонисты простагландинов и их применение для лечения заболеваний костей
ATE150299T1 (de) Verwendung von derivaten des 4-phenyl-1,2,3,4- tetrahydro-1-naphthalenamins zur behandlung von psychose, entzündung und als immununterdrücker
DE3033932A1 (de) Verfahren zur kaltsterilisation von blutgerinnungsfaktor viii enthaltenden praeparaten
CA2225470A1 (en) Method and apparatus for inactivating contaminants in blood products
EA199800829A1 (ru) Индуцирующий апоптоз продукт и способ его получения, индуктор апоптоза и способ индуцирования апоптоза, индуктор для дифференциации канцерогенных клеток, пищевой продукт, фармацевтические композиции и гигиеническое средство
ES2137225T3 (es) Eliminacion de anticuerpos de composiciones de derivados sanguineos reteniendo los factores de coagulacion.
CA2474448A1 (en) Inactivation of west nile virus and malaria using photosensitizers
Huang et al. Inactivation of dengue virus by methylene blue/narrow bandwidth light system
IL118258A (en) Method of treating extracoporeal blood or blood product to inactivate protozoa parasite by use of phthalocyanines
ATE203679T1 (de) Verfahren zur inaktivierung von viralen, parasitären und bakteriellen blutverunreinigungen
ATE286407T1 (de) Verfahren zur inaktivierung von pathogenen mittels breitspektrum-pulslicht
ATE78397T1 (de) Verwendung von p-chlorophenoxyazetat von n,ndimethylbiguanidzur behandlung von neuropathien und nervendegeneration.
EA199700241A1 (ru) Новые, определенные по составу смеси ферментов для выделения клеток и лечения ран
MX9301757A (es) Una nueva materia de composicion y metodos para usarla como bioreguladores
US6635679B2 (en) Methods and compositions for inactivating viruses
DE59707067D1 (de) Verfahren zur inaktivierung von lipidumhüllten viren mit lipopeptiden und neue antivirale lipopeptide
DE602005019998D1 (de) Verfahren zur sterilisation von biologischen präparaten
DE69029329D1 (de) Verfahren zur desinfektion von muskelskelettgeweben und so aufbereitete gewebe
Salle et al. An improved method for the evaluation of germicidal substances
Nickerson et al. Public health aspects of electronic food sterilization

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0702719

Country of ref document: EP

REN Ceased due to non-payment of the annual fee